![]() |
![]() |
![]() |
|
![]() |
Home | Free Dividend Report | GILD Dividend History | GILD News | Preferred Stock List | GILD Options Chain | GILD Message Board |
![]() |
|
![]() |
![]() GILD News — Articles, Videos, & Press ReleasesDespite M&A Spree, Biotech ETFs Slide on Mixed Earnings
![]() Biotech Stock Roundup: Regeneron Impresses in Q4, Gilead Slumps, MacroGenics Soars
![]() Gilead's (GILD) Late-Stage Study on Liver Disease Drug Fails
![]() Notable Tuesday Option Activity: EA, GILD, NKE
![]() Interesting GILD Put And Call Options For March 29th
![]() Why Gilead Sciences is a Top 25 Dividend Giant (GILD)
![]() Gilead Sciences Now #61 Largest Company, Surpassing Booking Holdings
![]() Wednesday Sector Leaders: Healthcare, Technology & Communications
![]() Biotech Stock Roundup: Celgene Tops in Q4, Gilead Disappoints, ALKS & AVEO Sink
![]() Alphabet (GOOGL) Outperforms Estimates, Gilead (GILD) Mixed
![]() Notable Monday Option Activity: BABY, GILD, VRNT
![]() Will Gilead (GILD) Q4 Earnings Disappoint on Weak HCV Sales?
![]() Interesting GILD Put And Call Options For March 22nd
![]() Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
![]() iShares U.S. Healthcare ETF Experiences Big Inflow
![]() Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
![]() Notable Friday Option Activity: WYNN, GS, GILD
![]() Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
![]() Gilead Sciences (GILD) Gains But Lags Market: What You Should Know
![]() Noteworthy Wednesday Option Activity: VUZI, GILD, SCVL
![]() Biotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD Deal
![]() Alexion's Ultomiris Gets Early FDA Nod for Rare Blood Disorder
![]() iShares Nasdaq Biotechnology ETF Experiences Big Outflow
![]() Bristol-Myers to Sell French Consumer Health Unit for $1.6B
![]() Gilead Partners with Scholar Rock for Fibrotic Disease Drugs
![]() Vertex's (VRTX) 3rd Study on Pain Drug Meets Primary Endpoint
![]() Evofem Shares Up as Birth Control Gel Succeeds in Phase III
![]() Puma Biotech's Nerlynx Ups Survival in Third-Line Breast Cancer
![]() Gilead Sciences (GILD) Stock Moves -0.69%: What You Should Know
![]() Mylan (MYL) Gets Favorable Ruling Against Sanofi's Lantus
![]() AMAG to Acquire Ciraparantag Maker Perosphere Pharmaceuticals
![]() 5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride
![]() The Zacks Analyst Blog Highlights: Gilead Sciences, Conatus Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Exelixis
![]() Gilead Sciences a Top Socially Responsible Dividend Stock With 3.4% Yield (GILD)
![]() Notable Wednesday Option Activity: NDSN, GILD, TLRD
![]() Biotech Stock Roundup: Gilead to Get New CEO, Biogen In-Licenses Candidate
![]() The Zacks Analyst Blog Highlights: Gilead Sciences, Alexion Pharmaceuticals, Regeneron Pharmaceutical and Biogen
![]() Ex-Dividend Reminder: New Jersey Resources, Conmed and Gilead Sciences
![]() Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
![]() Gilead's (GILD) Harvoni and Descovy Get Approval in China
![]() Amgen's BiTE Immunotherapies Show Promise in Early Studies
![]() Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
![]() Shire's Takhzyro Gets European Nod for Hereditary Angioedema
![]() FDA Committee to Review Amgen's (AMGN) Osteoporosis Candidate
![]() iShares Nasdaq Biotechnology ETF Experiences Big Outflow
![]() Novartis (NVS) Receives EC Approval for Neulasta Biosimilar
![]() Pfizer's Epilepsy Drug Lyrica Gets Pediatric Exclusivity
![]() Celgene & Bluebird's CAR T Therapy Study Completes Enrollment
![]() Aileron Inks Collaboration Deal With Pfizer for Cancer Combo
![]() Zafgen (ZFGN) Plunges as FDA Puts Hold on Diabetes Drug Trial
![]() Alnylam, Vir Begin Phase I/II Study on Hepatitis B Candidate
![]() Bristol-Myers' Opdivo-Yervoy Combo Fails in Lung Cancer Trial
![]() Eyenovia Initiates Phase III Study for Mydriasis Candidate
![]() Bayer's TRK Inhibitor Gets FDA Nod for Advanced Solid Tumors
![]() Gilead's HIV Franchise, CAR T Therapy Likely to Propel Growth
![]() Novartis Gets Approval for Gene Therapy Luxturna in Europe
![]() Biotech Stock Roundup: GILD's Drug Wins Nod in China, Arena Up On Licensing Deal
![]() Should Value Investors Consider Gilead (GILD) Stock Now?
![]() Gilead's Vemlidy Gets Approval in China for HBV Infection
![]() Emergent's (EBS) Zika Vaccine Candidate Meets Study Endpoint
![]() Novartis (NVS) Gets FDA Nod for Label Expansion of Promacta
![]() Amgen's Blincyto Gets Positive CHMP Opinion for Line Extension
![]() Bristol-Myers' Opdivo Receives Positive CHMP Opinion for RCC
![]() Sangamo's Shares Drop on Rating Downgrade, Pipeline Woes
![]() Biotech Stock Roundup: Gilead, Regeneron Present Data, Cocrystal Pharma Surges
![]() Roche's Tecentriq Gets Priority Review for Breast Cancer
![]() Cronos (CRON) to Report Q3 Earnings: What's in the Offing?
![]() Medicines Company (MDCO) Q3 Loss Widens, Inclisiran in Focus
![]() Gilead Sciences Now #59 Largest Company, Surpassing Booking Holdings
![]() GILD December 14th Options Begin Trading
![]() SPTM, TXN, GILD, LMT: Large Inflows Detected at ETF
![]() Noteworthy Wednesday Option Activity: GILD, WING, VEEV
![]() iShares Nasdaq Biotechnology ETF Experiences Big Outflow
![]() Gilead Sciences Breaks Above 200-Day Moving Average - Bullish for GILD
![]() Notable Tuesday Option Activity: GS, CMG, GILD
![]() IBB, GILD, BIIB, CELG: Large Inflows Detected at ETF
![]() Interesting GILD Put And Call Options For November 30th
![]() Noteworthy Thursday Option Activity: CBLK, GILD, AMTD
![]() Interesting GILD Put And Call Options For November 23rd
![]() Notable ETF Outflow Detected - IBB, GILD, BIIB, CELG
![]() Notable Wednesday Option Activity: ISRG, CELG, GILD
![]() IBB, BIIB, GILD, CELG: Large Outflows Detected at ETF
![]() GILD November 2nd Options Begin Trading
![]() Ex-Dividend Reminder: El Paso Electric, DTE Energy and Gilead Sciences
![]() Noteworthy Friday Option Activity: UBNT, ROKU, GILD
![]() Interesting GILD Put And Call Options For October 26th
![]() IBB, GILD, CELG, REGN: Large Outflows Detected at ETF
![]() Notable Friday Option Activity: ADBE, FB, GILD
![]() GILD Makes Notable Cross Below Critical Moving Average
![]() Noteworthy Thursday Option Activity: PRGO, OXY, GILD
![]() iShares Nasdaq Biotechnology ETF Experiences Big Outflow
![]() Gilead Sciences Takes Over #54 Spot From PayPal Holdings
![]() iShares Nasdaq Biotechnology ETF Experiences Big Inflow
![]() Notable Wednesday Option Activity: GRPN, GILD, SPWR
![]() Gilead Sciences (GILD) Shares Cross 3% Yield Mark
![]() Bullish Two Hundred Day Moving Average Cross - GILD
![]() Noteworthy Friday Option Activity: GILD, OMC, ADSK
![]() August 10th Options Now Available For Gilead Sciences (GILD)
![]() August 3rd Options Now Available For Gilead Sciences (GILD)
![]() Noteworthy Wednesday Option Activity: ANET, TPX, GILD
![]() Ex-Dividend Reminder: Chesapeake Utilities, Gilead Sciences and Owens & Minor
![]() Gilead Sciences a Top Socially Responsible Dividend Stock With 3.2% Yield (GILD)
![]() iShares Nasdaq Biotechnology ETF Experiences Big Inflow
![]() Noteworthy Monday Option Activity: MA, GILD, WDC
![]() Notable Monday Option Activity: DCO, GILD, ASNA
![]() Gilead Sciences Becomes #41 Most Shorted Nasdaq 100 Component, Replacing Lam Research
![]() Notable Thursday Option Activity: MAR, GILD, ABBV
![]() Interesting GILD Put And Call Options For July 20th
![]() See Which Of The Latest 13F Filers Holds Gilead Sciences
![]() iShares Nasdaq Biotechnology ETF Experiences Big Outflow
![]() Noteworthy Wednesday Option Activity: MLM, GILD, IBKR
![]() Gilead Sciences (GILD) Shares Cross 3% Yield Mark
![]() Notable Two Hundred Day Moving Average Cross - GILD
![]() Notable Wednesday Option Activity: DDD, GILD, HD
![]() Notable Tuesday Option Activity: GILD, LE, PYPL
![]() SPDR Portfolio S&P 500 Growth ETF Experiences Big Inflow
![]() |
![]() |
|
![]() |